This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Louise Michelle Birch: Innovator in Neurological Treatments
Introduction
Louise Michelle Birch is a prominent inventor based in Hertfordshire, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurological disorders. With a total of 2 patents, her work focuses on innovative solutions for cognitive deficits associated with conditions such as Alzheimer-type dementia and dementia with Lewy bodies.
Latest Patents
Birch's latest patents include the development of 4-azaindole derivatives. These compounds serve as modulators of the muscarinic acetylcholine receptor (mAChR) M1. They may be effective in preventing or modifying the symptoms of cognitive deficits linked to neurological disorders. Additionally, her patents encompass a pharmaceutical composition that includes a 4-azaindole derivative as an active ingredient.
Career Highlights
Louise Birch is currently associated with Eisai R&D Management Co., Ltd., where she continues to advance her research in the pharmaceutical sector. Her innovative work has the potential to significantly impact the treatment landscape for patients suffering from cognitive impairments.
Collaborations
Some of her notable coworkers include Andrew Payne and Jose Luis Castro Pineiro. Their collaborative efforts contribute to the ongoing research and development of effective treatments in the field.
Conclusion
Louise Michelle Birch stands out as a dedicated inventor whose work in neurological treatments is paving the way for advancements in patient care. Her contributions are vital in addressing the challenges posed by cognitive deficits in various neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
